#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2586	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2490	308.2	0	.	n	.	0	A69G	SNP	69	69	A	565	565	G	379	G,A	230,82	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2586	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2490	308.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1946	1946	T	372	T	305	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2586	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2490	308.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1680	1680	C	380	C	300	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2586	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2490	308.2	0	HET	.	.	.	C207T	.	207	207	C	703	703	C	349	C,T	195,81	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4294	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3970	323.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1903	1903	A	365	A,G	290,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4294	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3970	323.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2537	2537	C	427	C	341	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4294	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3970	323.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2611	2611	A	442	A,C	343,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4294	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3970	323.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3163	3163	C	403	C,A,G	313,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_G_01367c	folP.WHO_G_01367c	1	1	539	354	folP	852	852	99.88	folP.l15.c4.ctg.1	1860	56.6	0	.	p	.	0	E151K	NONSYN	451	453	GAA	1004	1006	AAA	80;80;80	A;A,C;A	58;57,1;58	.	.
folP.WHO_G_01367c	folP.WHO_G_01367c	1	1	539	354	folP	852	852	99.88	folP.l15.c4.ctg.1	1860	56.6	1	SNP	p	R228S	1	.	.	682	684	AGC	1235	1237	AGC	77;79;79	A,G;G;C	61,1;66;64	folP.WHO_G_01367c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	832	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3702	67.2	1	SNP	p	S91F	0	.	.	271	273	TCC	643	645	TCC	69;70;70	T;C;C	52;55;58	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	832	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3702	67.2	1	SNP	p	D95G	0	.	.	283	285	GAC	655	657	GAC	72;71;73	G;A,G;C	57;54,1;56	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	832	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3702	67.2	1	SNP	p	D95N	0	.	.	283	285	GAC	655	657	GAC	72;71;73	G;A,G;C	57;54,1;56	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	368	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	1508	72.6	1	SNP	p	G45D	0	.	.	133	135	GGC	480	482	GGC	103;103;105	G,A;G;C	81,1;82;84	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	202	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1255	48.3	0	.	n	.	0	A197.	DEL	197	197	A	714	714	A	96	A	73	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	942	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3148	89.0	1	SNP	p	D86N	0	.	.	256	258	GAC	658	660	GAC	136;135;135	G;A;C	104;102;109	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	942	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3148	89.0	1	SNP	p	S87W	0	.	.	259	261	AGT	661	663	AGT	134;135;135	A,G;G;T	104,1;107;107	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	942	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3148	89.0	1	SNP	p	S87R	0	.	.	259	261	AGT	661	663	AGT	134;135;135	A,G;G;T	104,1;107;107	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	942	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3148	89.0	1	SNP	p	S87I	0	.	.	259	261	AGT	661	663	AGT	134;135;135	A,G;G;T	104,1;107;107	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	942	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3148	89.0	1	SNP	p	S88P	0	.	.	262	264	TCC	664	666	TCC	136;136;134	T;C;C	105;109;108	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	786	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3004	78.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1770	1772	GGC	110;110;112	G;G;C	87;84;88	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	676	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2655	76.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1441	1443	GCA	113;113;115	G;C;A	84;87;85	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	676	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2655	76.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1444	1446	ATC	115;114;114	A;T;C	86;87;91	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	676	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2655	76.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1456	1458	GTG	113;113;113	G;T;G,T,C	87;83;83,1,1	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	676	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2655	76.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1456	1458	GTG	113;113;113	G;T;G,T,C	87;83;83,1,1	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	676	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2655	76.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1960	1962	ACC	78;79;79	A;C;C	63;64;68	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	676	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2655	76.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2014	2016	GCG	65;64;65	G;C,G;G	55;49,2;50	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	676	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2655	76.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2014	2016	GCG	65;64;65	G;C,G;G	55;49,2;50	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	676	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2655	76.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2137	2139	GGC	72;72;71	G,C;G;C	52,1;56;55	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	676	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2655	76.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2146	2148	GGC	71;70;70	G,C;G;C	52,1;53;54	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	676	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2655	76.0	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2164	2166	CTG	67;67;67	C;T;G,T	52;49;52,1	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	878	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3446	76.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1819	1821	CCG	70;70;71	C;C;G,T	53;55;55,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	416	porA	1146	1146	99.65	porA.l6.c4.ctg.1	2096	59.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	749	749	C	52	C	40	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	534	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	2020	79.1	0	.	p	.	0	N38E	NONSYN	112	114	AAT	584	586	GAA	118;119;118	G,T;A;A	90,1;95;94	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	534	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	2020	79.1	0	.	p	.	0	N134D	NONSYN	400	402	AAT	872	874	GAT	97;96;96	G;A,G;T	79;80,1;79	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	534	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	2020	79.1	0	.	p	.	0	P175S	NONSYN	523	525	CCA	995	997	TCA	106;106;107	T;C;A	84;83;83	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	534	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	2020	79.1	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1124	1126	GTC	122;122;121	G;T;C	101;101;101	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	534	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	2020	79.1	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1136	1138	TCT	125;123;124	T;C;T	101;103;101	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	534	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	2020	79.1	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1454	1456	GCA	114;117;117	G;C;A	88;88;90	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	534	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	2020	79.1	1	SNP	p	G120K	1	.	.	358	360	AAG	830	832	AAG	95;95;95	A;A;G,T	77;77;77,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	534	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	2020	79.1	1	SNP	p	D121N	0	.	.	361	363	GAC	833	835	GAC	94;93;94	G;A;C	71;72;79	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	534	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	2020	79.1	1	SNP	p	A121D	1	.	.	361	363	GAC	833	835	GAC	94;93;94	G;A;C	71;72;79	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	1812	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5180	104.5	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2155	2157	AAT	110;111;110	A;A,G;T	83;87,1;88	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	250	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1343	55.8	1	SNP	p	V57M	1	.	.	169	171	ATG	700	702	ATG	112;112;112	A;T;G,T	92;85;88,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
